Skip to content
healthcare.dev

Mesalamine

NDC 63304-175, Mesalamine, tablet, delayed release, from Sun Pharmaceutical Industries, Inc..

Product NDC
63304-175
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211858
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63304-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE1.2 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
63304-175-1363304017513120 TABLET, DELAYED RELEASE in 1 BOTTLE (63304-175-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fd8b02de-7dfa-444d-a1f8-1436b578e0cb
  • NADAC price for package 63304017513

    GET /v1/drugs/nadac/63304017513

Use it

Look up 63304-175 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63304-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63304-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.